PHARMACAN CAPITAL CORP. ("MJN")
[formerly Searchtech Ventures Inc. ("MJN.P")]
BULLETIN TYPE: Qualifying Transaction-Completed/New Symbol, Name Change, Consolidation, Resume Trading
BULLETIN DATE: December 16, 2014
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing the Company's Qualifying Transaction described in its Filing Statement dated November 28, 2014. As a result, at the opening on Wednesday, December 17, 2014, the Company will no longer be considered a Capital Pool Company. The Qualifying Transaction includes the following:
The Company acquired all the issued and outstanding shares of Hortican Inc. dba PharmaCan Capital ("PharmaCan") by way of a three cornered amalgamation (the "Amalgamation"), and issued 33,207,048 Common Shares to the shareholders of PharmaCan. Prior to the Amalgamation, the Company consolidated all of its issued and outstanding common shares on a 7 old for 1 new basis and changed its name to "PharmaCan Capital Corp.". Under the Amalgamation, all shareholders of PharmaCan exchanged their common shares of PharmaCan in return for post-consolidated common shares of the Company on a 2.1339 for 1 basis and the convertible securities of PharmaCan remained convertible under their terms for like securities of the Company in lieu of PharmaCan securities, also on a 2.1339 for 1 basis. As a result of the Amalgamation, PharmaCan has become a wholly-owned subsidiary of the Company.
For more information about the transaction, please see the Filing Statement dated November 28, 2014.
In addition, the Exchange has accepted for filing the following:
Name Change and Consolidation:
Pursuant to the Amalgamation, shareholders approved on October 3, 2014, the Company's capital consolidation on a 7 old for 1 new basis. The name of the Company has also been changed from Searchtech Ventures Inc. to PharmaCan Capital Corp.
Effective at the opening on Wednesday, December 17, 2014, the common shares of PharmaCan Capital Corp. will commence trading on the Exchange and the Shares of Searchtech Ventures Inc. will be delisted.
Resume Trading:
Further to TSX Venture Exchange bulletin dated July 17, 2014, trading in the securities of the resulting issuer will resume at the opening on Wednesday, December 17, 2014.
Capitalization: Unlimited shares with no par value of which
34,786,562 shares are issued and outstanding
Escrow: 8,108,822 shares
Symbol: MJN (same symbol as CPC but with .P removed)
CUSIP Number: 717115109 (NEW)
Transfer Agent: TMX Equity Transfer Services
The Company is classified as a "Holding" company.
Company Contact: Paul Rosen, President and Chief Executive Officer
Company Address: 76 Stafford St., Suite 302, Toronto, ON, M6J 2S1
Company Phone Number: (416) 728-1295
Company Email Address: paul@pharmacancapital.com
________________________________
|
|
